CIK 0000318154
- Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953540776
- Phone
- +1 805-447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 165,529 shares at $302.06 ($49,999,938)
- 4 Grant or award Director acquired 282.42 shares (grant or award)
- 4 Grant or award Director acquired 760 shares (grant or award)
- 4 Grant or award Director acquired 347.6 shares (grant or award)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Grant or award Director acquired 837 shares (grant or award)
- 4 Open-market sale Director sold 1,000 shares at $250.59 ($250,590)
- 4 Open-market sale SVP & CCO sold 2,500 shares at $252.51 ($631,272)
- 4 Open-market sale Director sold 250 shares at $251.78 ($62,945)
Page 23 of 99 · 1,961 filings